Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma
Letters in Drug Design & Discovery · 2026-02 · 23 (2) · 100376
DOI: 10.1016/j.lddd.2026.100376 ↗Kurz gefasst
Fachartikel in der Zeitschrift Letters in Drug Design & Discovery, 2026-02. Verfasst von Temitope C. Aribigbola und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Aribigbola, T. C., Omoboyowa, D. A., Agrawal, M., Adelaja, A. O., Aiyeku, B., & Zaki, M. E. (2026). Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma. Letters in Drug Design & Discovery, 23(2), 100376. https://doi.org/10.1016/j.lddd.2026.100376
Vancouver
Aribigbola TC, Omoboyowa DA, Agrawal M, Adelaja AO, Aiyeku B, Zaki ME. Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma. Letters in Drug Design & Discovery. 2026;23(2):100376. doi:10.1016/j.lddd.2026.100376
BibTeX
@article{Aribigbola2026,
author = {Aribigbola, Temitope C. and Omoboyowa, Damilola A. and Agrawal, Mohit and Adelaja, Abayomi O. and Aiyeku, Babasola and Zaki, Magdi E.A.},
title = {Network pharmacology and machine learning-driven virtual screening with dynamic simulations of natural compounds for glioblastoma},
journal = {Letters in Drug Design & Discovery},
year = {2026},
volume = {23},
number = {2},
pages = {100376},
doi = {10.1016/j.lddd.2026.100376}
}
EUVIMED